Abstract

Frustrations with the low impact of ovarian cancer screening strategies, and a plateau in overall survival statistics, highlight the urgent need for novel methods to control this disease. In September of 2010, British Columbia announced a prevention campaign aimed at women at low risk/general population risk for developing ovarian cancer. Five years later we look back at the rationale, uptake, and safety data pertaining to opportunistic salpingectomy in British Columbia and beyond, and share data on the health economics and cancer outcomes (historic and projected) associated with this surgical intervention.